Qiagen (QGEN) Net Margin (2009 - 2025)

Qiagen (QGEN) posted Net Margin of 96.59% for Q4 2025, up 295.58% sequentially from 24.42% in Q3 2025, and up 4518.0% YoY from 2.09% in Q4 2024.

Qiagen (QGEN) Net Margin (2009 - 2025) Analysis & Trends

Qiagen has reported Net Margin for 17 years, with the latest figure at 96.59% in Q4 2025.

Quarterly Net Margin rose 4518.0% year-over-year to 96.59% in Q4 2025, while the trailing twelve-month figure through Mar 2026 was 37.36% (up 317.0% YoY) and the FY2025 annual result came in at 24.98%, up 16.0% from the prior year.
Net Margin climbed to 96.59% in Q4 2025 per QGEN's latest filing, from 24.42% in the prior quarter.
Over five years, Net Margin peaked at 96.59% in Q4 2025 and troughed at 16.33% in Q2 2023.
A 5-year average of 33.41% and a median of 24.74% in 2025 frame the typical range for Net Margin.
The sharpest annual moves came in 2023 and 2024: Net Margin surged 6918 bps in 2023, then slumped 4227 bps in 2024.
Over 5 years, Net Margin stood at 54.1% in 2021, then sank by 55 bps to 24.5% in 2022, then surged by 282 bps to 93.68% in 2023, then slumped by 45 bps to 51.41% in 2024, then jumped by 88 bps to 96.59% in 2025.
According to Business Quant data, Net Margin over the past three periods registered 96.59%, 24.42%, and 24.74% for Q4 2025, Q3 2025, and Q2 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Margin (Qtr)
1	Thermo Fisher Scientific	213.88 Bn	209.81 Bn	8.34 Bn	14.65%
2	Danaher	140.65 Bn	136.30 Bn	3.61 Bn	13.89%
3	Idexx Laboratories	46.02 Bn	45.83 Bn	779.09 Mn	27.82%
4	Agilent Technologies	39.85 Bn	38.05 Bn	990.00 Mn	18.47%
5	Iqvia Holdings	39.20 Bn	37.12 Bn	1.44 Bn	5.52%
6	Natera	38.80 Bn	37.70 Bn	696.04 Mn	-12.22%
7	Illumina	30.11 Bn	28.94 Bn	770.00 Mn	17.86%
8	Mettler Toledo International	28.66 Bn	28.61 Bn	650.22 Mn	22.67%
9	Quest Diagnostics	26.24 Bn	25.61 Bn	1.03 Bn	10.65%
10	Qiagen	8.65 Bn	8.65 Bn	-	-

Download Data